Literature DB >> 9613630

Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China.

J P Cao1, L Y Zhang, J Q Zhu, D P Chin.   

Abstract

SETTING: The tuberculosis component of the Infectious and Endemic Disease Control Project in the People's Republic of China is the largest single tuberculosis control project in the world using directly-observed therapy and standardized intermittent regimens.
OBJECTIVE: To determine the two-year relapse and mortality rates following completion of treatment.
DESIGN: A prospective cohort study of 649 cases cured in this project. The 306 new and 343 retreatment cases were treated under field conditions with 2H3R3Z3S3/4H3R3 and 2H3R3Z3E3S3/6H3R3E3, respectively. Following treatment completion, two sputum samples were collected every six months for two years and examined for acid-fast bacilli. Causes of death were identified.
RESULTS: The two-year relapse rates for new and retreatment cases were 3.3% and 5.6%, respectively. Retreatment cases with delayed sputum conversion had a greater risk for subsequent relapse. The two-year mortality rate for new and retreatment cases was 3.3% and 8.5%, respectively. The higher mortality rate in retreatment cases was not attributable to relapse of disease, but rather to non-infectious sequelae of tuberculosis.
CONCLUSION: The use of directly-observed intermittent regimens is effective in permanently removing infectious tuberculosis cases from the community.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613630

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

Review 1.  Directly observed therapy (DOT) for tuberculosis: why, when, how and if?

Authors:  L P Ormerod
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Authors:  David J Horne; Sarah E Royce; Lisa Gooze; Masahiro Narita; Philip C Hopewell; Payam Nahid; Karen R Steingart
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

3.  A follow up study on revised national tuberculosis control programme (rntcp): results from a single centre study.

Authors:  R Prasad; S K Verma; P Shrivastava; S Kant; R A S Kushwaha; S Kumar
Journal:  Lung India       Date:  2008-10

4.  Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.

Authors:  Grace H Huynh; Daniel J Klein; Daniel P Chin; Bradley G Wagner; Philip A Eckhoff; Renzhong Liu; Lixia Wang
Journal:  BMC Med       Date:  2015-04-21       Impact factor: 8.775

5.  (18)F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis.

Authors:  Yun-Jeong Jeong; Jin Chul Paeng; Hyun-Yeol Nam; Ji Sun Lee; Sang-Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

6.  Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China.

Authors:  Li Yuan; Hui Zhang; Changming Zhou; Weili Jiang; Qi Zhao; Xu Biao
Journal:  BMC Infect Dis       Date:  2017-01-13       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.